Chronic liver disease

There are 209 papers on chronic liver disease in aging research: 8 trials and 114 observational studies in people, 12 in animals, 68 reviews. The newest story, Nov 11, 2026: “Damaged chromosome ends limit liver cell flexibility in mice”.

Disease

209 papers study it307 more mention it57 findings

42 new papers in 30 daysSee all 516 papers on chronic liver disease

At a glance

Chronic liver disease is linked with higher blood PhenoAge and IMM-AGE and higher skeletal-muscle epigenetic age in a human study, which also reports higher muscle cellular senescence in patients. Human cohorts link frailty with chronic liver disease and link liver disease with higher heart disease risk and mortality after femoral neck fracture surgery.

57 findings in 40 papers from 2015 to 2026, 15 of them since April 2026

“and chronic liver disease (HR 1.65, 95% CI 1.65 to 1.71, p < 0.001).”
Prevalence and long-term outcomes of patients with life-limiting illness admitted to intensive care units in Australia and New ZealandCritical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine2024doi:10.1016/j.ccrj.2024.02.001
  • Human trial8
  • Humans114
  • Animals12
  • In silico5

Interventions

1

Deprivation-related adverse childhood experiences

no changein humans1

1 study
  1. Deprivation-related adverse childhood experiences were not clearly linked with chronic liver disease in humans.

    “and no significant associations with liver disease risk across all exposure levels”

    Humans

    Association of adverse childhood experiences and gastrointestinal and liver diseases among middle-aged and elderly adults in China

    Epidemiology and psychiatric sciences

More on Deprivation-related adverse childhood experiences

Effects

6

IMM-AGE

upin humans1

1 study
  1. Chronic liver disease is linked with higher IMM-AGE in CLD patients compared with age-matched healthy controls (2-fold, p < 0.0001).

    “Analysis of the IMM-Age score indicated a prematurely aged immune phenotype in CLD patients that was 2-fold greater than that observed in age-matched healthy controls (p < 0.0001).”

    Humansin CLD patients compared with age-matched healthy controlsblood

    Accelerated aging of skeletal muscle and the immune system in patients with chronic liver disease

    Experimental & molecular medicine

More on IMM-AGE

PhenoAge

upin humans1

1 study
  1. Chronic liver disease is linked with higher PhenoAge in CLD patients compared with healthy controls (p < 0.0001).

    “Similarly, blood cell epigenetic age was significantly greater than that in control individuals, as calculated using the PhenoAge (p < 0.0001), DunedinPACE (p < 0.0001), or Hannum (p = 0.01) epigenetic clocks”

    Humansin CLD patients compared with healthy controlsblood

    Accelerated aging of skeletal muscle and the immune system in patients with chronic liver disease

    Experimental & molecular medicine

More on PhenoAge

Cellular senescence

upin humans1

1 study
  1. Chronic liver disease is linked with higher cellular senescence in CLD patients.

    “The skeletal muscle transcriptome was also enriched for genes associated with cellular senescence.”

    Humansin CLD patientsskeletal muscle

    Accelerated aging of skeletal muscle and the immune system in patients with chronic liver disease

    Experimental & molecular medicine

More on Cellular senescence

Epigenetic age

upin humans1

1 study
  1. Chronic liver disease is linked with higher epigenetic age in CLD patients compared with healthy controls (+2.2 ± 4.8 years compared with healthy controls at -3.0 ± 3.2 years, p = 0.0001).

    “Accelerated biological aging of the skeletal muscle tissue of CLD patients was detected, as evidenced by an increase in epigenetic age compared with chronological age”

    Humansin CLD patients compared with healthy controlsskeletal muscle

    Accelerated aging of skeletal muscle and the immune system in patients with chronic liver disease

    Experimental & molecular medicine

More on Epigenetic age

Survival

downin humans1HR 1.65

1 study
  1. Chronic liver disease is linked with worse survival in humans after multivariate analysis in patients with LLI admitted to ICUs (HR 1.65, 95% CI 1.65 to 1.71, p < 0.001).

    “and chronic liver disease (HR 1.65, 95% CI 1.65 to 1.71, p < 0.001).”

    Humansafter multivariate analysis in patients with LLI admitted to ICUs

    Prevalence and long-term outcomes of patients with life-limiting illness admitted to intensive care units in Australia and New Zealand

    Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine

Animal Naming Test

no changein humans1

1 study
  1. Chronic liver disease was not clearly linked with Animal Naming Test in humans.

    “CLD or cirrhosis was not independently associated with ANT.”

    Humansn = 6,661

    Animal Naming Test Is Associated With Poor Patient-Reported Outcomes and Frailty in People With and Without Cirrhosis: A Prospective Cohort Study

    Clinical and translational gastroenterology

More on Animal Naming Test

Upstream

2

Depressive symptoms

mediatesin humans2

2 studies
  1. Depressive symptoms are linked with chronic liver disease in humans (10.7%).

    “depressive symptoms accounted for 10.7% (P = 0.003) of the association between threat-related ACEs and liver disease risk”

    Humans

    Association of adverse childhood experiences and gastrointestinal and liver diseases among middle-aged and elderly adults in China

    Epidemiology and psychiatric sciences

  2. Depressive symptoms are linked with chronic liver disease in humans (25.6% of total effect).

    “Depressive symptoms mediated 25.6% of the total effect, which was statistically significant yet relatively modest in magnitude.”

    Humans5 yearsn = 7,363

    Longitudinal frailty trajectories and risk of incident chronic liver disease among middle-aged and older Chinese adults: the mediating role of depressive symptoms

    Research squarePreprint

PLA2G6

downin mice1

1 study
  1. PLA2G6 protects against chronic liver disease in mice (natural pathogen exposure).

    “global PLA2G6 inactivation combined with natural infection accelerates progression of chronic liver disease in both male and female mice”

    Animalsnatural pathogen exposureliver

    iPLA2β-null mice exposed to natural pathogens exhibit hepatocellular fibrotic injury with male-biased alteration of glycerolipid metabolism

    Frontiers in immunology

More on PLA2G6

Associations

35

Mortality

upin humans6OR 2.188–4.324

6 studies
  1. Chronic liver disease is associated with mortality in humans (coexisting with mental health disorders) (2.67 to 4.26 per 100,000).

    “The overall AAMR rose from 2.67 per 100,000 in 1999 to 4.26 in 2023.”

    Humanscoexisting with mental health disorders1999-2023n = 148,757

    Trends and Disparities in Mortality From Coexisting Chronic Liver Disease and Mental Disorders in the US (1999–2023) with Forecasts to 2030

    Research SquarePreprint

  2. Chronic liver disease is linked with a higher risk of mortality in hospitalized adults with RSV (aHR 4.21, 1.54–11.49).

    “and chronic liver disease (RSV 4.21, 1.54–11.49; influenza A 2.81, 1.23–6.40).”

    Humansin hospitalized adults with RSV

    Comorbidity Risk Factors and Mortality in Patients Hospitalized with Respiratory Syncytial Virus and Influenza A: a Retrospective Observational Cohort Study

    Research SquarePreprint

  3. Chronic liver disease is linked with a higher risk of mortality in humans after femoral neck fracture surgery (OR 2.188, 95% CI 1.802-2.489).

    “chronic liver disease (CLD) (OR 2.188; 95% CI, 1.802-2.489)”

    Humansafter femoral neck fracture surgery1 year

    Epidemiology, treatment, and mortality of femoral neck fractures in patients over the age of 65 years: a nationwide retrospective cohort study of 83,789 cases in Turkey

    Hip international : the journal of clinical and experimental research on hip pathology and therapy

  4. Chronic liver disease is linked with a higher risk of mortality in humans (synergy with disability) (106.7 (95% CI -16.4, 229.9) excess deaths per 1000 persons).

    “large positive interaction contrasts (95 % CIs) of 106.7 (-16.4, 229.9), 45.7 (6.9, 84.5), 45.1 (-15.0, 105.2), and 42.9 (-41.0, 126.9) excess deaths per 1000 persons”

    Humanssynergy with disability

    Additive interaction of disability with chronic conditions on mortality risk in middle-aged and older adults in Spain

    Disability and health journal

  5. Chronic liver disease is linked with a higher risk of mortality in humans (mild traumatic brain injury) (HR 4.59 [95%CI 2.56-8.24]).

    “chronic liver disease (HR 4.59 [95%CI 2.56-8.24], p < 0.001)”

    Humansmild traumatic brain injury

    Risk Factors Analysis for 90-Day Mortality of Adult Patients with Mild Traumatic Brain Injury in an Italian Emergency Department

    Geriatrics (Basel, Switzerland)

  6. Chronic liver disease is linked with a higher risk of mortality in humans (elderly ED-ICU patients) (adjusted OR 4.324, 95% CI 1.170–15.979).

    “chronic liver disease (CLD) (4.324; 1.170, 15.979; 0.028)”

    Humanselderly ED-ICU patientsn = 503

    Clinical profile, outcomes and predictors of mortality in elderly patients admitted to the emergency medicine intensive care unit of a teaching hospital - A single-center registry

    Journal of family medicine and primary care

Frailty

upin humans2HR 1.48–1.76

2 studies
  1. Frailty is linked with a higher risk of chronic liver disease in humans after adjustment for confounders (HR 1.48, 95% CI 1.16-1.90).

    “individuals in the frailty-worsening trajectory group had a 48% increased risk of incident chronic liver disease (CLD) (HR = 1.48, 95% CI: 1.16-1.90)”

    Humansafter adjustment for confounders5 yearsn = 7,363

    Longitudinal frailty trajectories and risk of incident chronic liver disease among middle-aged and older Chinese adults: the mediating role of depressive symptoms

    Research squarePreprint

  2. Frailty predicts chronic liver disease in humans (HR = 1.76, 95% CI: 1.45-2.12).

    “baseline frailty independently predicted incident CLD (prefrail: HR = 1.35, 95% CI: 1.16-1.56; frail: HR = 1.76, 95% CI: 1.45-2.12).”

    Humans

    Association Between Frailty and Chronic Liver Disease Among Middle-Aged and Older Adults in China: A Nationwide Cohort Study Based on the CHARLS

    Geriatrics & gerontology international

  3. Frailty is associated with chronic liver disease in humans (OR = 3.14, 95% CI: 2.46-4.02).

    “in fully adjusted models, pre-frail (OR = 1.84, 95% CI: 1.49-2.28) and frail (OR = 3.14, 95% CI: 2.46-4.02) groups had elevated risks compared with nonfrail individuals.”

    Humans

    Association Between Frailty and Chronic Liver Disease Among Middle-Aged and Older Adults in China: A Nationwide Cohort Study Based on the CHARLS

    Geriatrics & gerontology international

Depressive symptoms

upin humans2HR 1.34–1.65

2 studies
  1. Depressive symptoms are linked with a higher risk of chronic liver disease in humans (fully adjusted model) (HR 1.34, 95% CI 1.12-1.59).

    “compared with the non-depressed group, the HR for mild depression was 1.34 (95% CI: 1.12-1.59, p = 0.001)”

    Humansfully adjusted modelmean follow-up of 8.77 yearsn = 9,549

    Association Between Depressive Symptoms and Risk of New-Onset Chronic Liver Disease Among Middle-Aged and Elderly Chinese Adults: A Prospective Cohort Study Based on the China Health and Retirement Longitudinal Study

    Healthcare (Basel, Switzerland)

  2. Depressive symptoms are linked with a higher risk of chronic liver disease in humans (moderate depressive symptoms vs none/mild) (HR 1.65, 95% CI 1.33-2.03).

    “hazard rates of CLD in those with moderate and severe depressive symptoms were 1.65 (95%CI, 1.33-2.03) and 1.80 (95%CI, 1.24-2.60)”

    Humansmoderate depressive symptoms vs none/mildn = 13,405

    Association of depressive symptoms with chronic liver disease among middle-aged and older adults in China

    Frontiers in psychiatry

Cellular senescence

upin reviews2

2 studies
  1. Cellular senescence raises the risk of chronic liver disease (aging or pathological stress).

    “its accumulation due to aging or pathological stress significantly contributes to chronic liver diseases”

    Reviewaging or pathological stressliver

    Navigating the complex role of senescence in liver disease

    Chinese medical journal

  2. Cellular senescence is associated with chronic liver disease.

    “their accumulation owing to ageing or pathological conditions contributes to the damage occurring in chronic diseases”

    Reviewliver

    Cell senescence in liver diseases: pathological mechanism and theranostic opportunity

    Nature reviews. Gastroenterology & hepatology

More on Cellular senescence

Microbiome composition

mixedin humans1upin humans1

2 studies
  1. Microbiome composition is associated with chronic liver disease in people with HIV.

    “associated with chronic liver disease (CLD)”

    Reviewin people with HIV

    HIV, the gut microbiome and clinical outcomes, a systematic review

    PloS one

  2. Microbiome composition raises the risk of chronic liver disease in humans.

    “Age-related gut dysbiosis can disrupt the communication between gut microbiota and the host, impacting the host's health and lifespan.”

    Review

    Impacts of gut microbiota alteration on age-related chronic liver diseases

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

More on Microbiome composition

TyG-Frailty Index

upin humans1OR 1.38–3.19

1 study
  1. TyG-Frailty Index is associated with chronic liver disease in humans (per unit increase) (OR = 1.38, 95% CI: 1.23–1.45).

    “Each unit increase in TyGFI was associated with a 38% higher odds of incident CLD (OR = 1.38, 95% CI: 1.23–1.45, p < 0.001).”

    Humansper unit increasen = 7,417

    The association of the combined triglyceride-glucose and frailty index with chronic liver disease: evidence from the CHARLS study

    BMC gastroenterology

  2. TyG-Frailty Index is linked with a higher risk of chronic liver disease in humans (highest vs lowest quartile) (OR = 3.19, 95% CI: 2.16–4.80).

    “Participants in the highest TyGFI quartile exhibited the greatest risk of CLD (OR = 3.19, 95% CI: 2.16–4.80, p < 0.001).”

    Humanshighest vs lowest quartilen = 7,417

    The association of the combined triglyceride-glucose and frailty index with chronic liver disease: evidence from the CHARLS study

    BMC gastroenterology

More on TyG-Frailty Index

Heart disease

upin humans1HR 1.803–2.303

1 study
  1. Heart disease is linked with a higher risk of chronic liver disease in humans (HR: 2.303, 95% CI 1.813–2.924).

    “HD was associated with a higher risk of developing CLD (HR: 2.303, 95% CI 1.813–2.924).”

    Humansn = 6,917

    Bidirectional association between non-steatotic chronic liver disease and heart disease: the potential link of insulin resistance

    Cardiovascular diabetology

  2. Chronic liver disease is linked with a higher risk of heart disease in humans (HR:1.803, 95% CI 1.376–2.362).

    “CLD was associated with a significantly increased risk of incident HD (HR:1.803, 95% CI 1.376–2.362).”

    Humansn = 6,230

    Bidirectional association between non-steatotic chronic liver disease and heart disease: the potential link of insulin resistance

    Cardiovascular diabetology

More on Heart disease

TyGwaist

upin humans1HR 1.4

1 study
  1. TyGwaist is associated with chronic liver disease in humans (Highest versus lowest quartile; fully adjusted) (HR 1.40, 95% CI 1.09–1.81).

    “The hazard ratio (95% confidence interval) for the highest quartile of TyG index, TyGBMI, and TyGwaist was 1.42(1.10-1.83), 1.62(1.25-2.09) and 1.40(1.09-1.81) after full adjustment”

    HumansHighest versus lowest quartile; fully adjusted7 yearsn = 9,156

    Association between triglyceride-glucose index and chronic liver disease: a longitudinal cohort study

    Annals of nutrition & metabolism

More on TyGwaist

TyGBMI

upin humans1HR 1.62

1 study
  1. TyGBMI is associated with chronic liver disease in humans (Highest versus lowest quartile; fully adjusted) (HR 1.62, 95% CI 1.25–2.09).

    “The hazard ratio (95% confidence interval) for the highest quartile of TyG index, TyGBMI, and TyGwaist was 1.42(1.10-1.83), 1.62(1.25-2.09) and 1.40(1.09-1.81) after full adjustment”

    HumansHighest versus lowest quartile; fully adjusted7 yearsn = 9,156

    Association between triglyceride-glucose index and chronic liver disease: a longitudinal cohort study

    Annals of nutrition & metabolism

More on TyGBMI

Triglyceride-glucose index

upin humans1HR 1.42

1 study
  1. Triglyceride-glucose index is associated with chronic liver disease in humans (Highest versus lowest quartile; fully adjusted) (HR 1.42, 95% CI 1.10–1.83).

    “Higher TyG index was associated with increased risk of CLD, independently of established risk factors.”

    HumansHighest versus lowest quartile; fully adjusted7 yearsn = 9,156

    Association between triglyceride-glucose index and chronic liver disease: a longitudinal cohort study

    Annals of nutrition & metabolism

More on Triglyceride-glucose index

All 35

Trial sponsors

Funding

14 grants since 2019

National Institute of Diabetes and Digestive and Kidney Diseases$6.8MJapan Society for the Promotion of Science¥6.5MAgence Nationale de la Recherche€1.3M

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 6Jan 2026: 29Feb 2026: 18Mar 2026: 30Apr 2026: 9May 2026: 7Jun 2026: 8Jul 2026: 22Aug 2026: 22Sep 2026: 14Oct 2026: 22Nov 2026: 21208 papers in 12 months
Journal of Hepatology

Damaged chromosome ends limit liver cell flexibility in mice

Mouse experiments found impaired shifts toward bile duct cells during chronic injury, but no substantial impairment of liver cell survival or basic metabolic function.Mouse experiments found impaired shifts toward bile duct cells during chronic injury, but no substantial impairment of liver cell survival or basic metabolic function.

Mouse studyMechanisms
Experimental Gerontology

Childhood adversity linked to chronic disease later in life

Childhood adversity was associated with 30% higher relative risk of heart and blood vessel disease in 7,184 Chinese adults aged 45 and older.Childhood adversity was associated with 30% higher relative risk of heart and blood vessel disease in 7,184 Chinese adults aged 45 and older.

Cohort · 7,184 peoplePopulations

See all 516 papers on chronic liver disease